1-(4-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)-5-propyl-1H-pyrazole-4-carboxylic acid, 95.0%, 500mg

Benzo[lmn][3,8]phenanthroline-1,3,6,8(2H,7H)-tetraone, 98%, 5g

3-((Dimethylamino)methyl)-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one hydrochloride, 98%, 100mg

6-Bromo-2H-1,3-benzodioxol-5-amine, 98%, 10g

2-METHYL-5-[4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL]-1,3,4-OXADIAZOLE, 95.0%, 10g

(4-Bromophenoxy)-acetonitrile, 95.0%, 100mg

(3-Fluoro-4-(methylsulfonyl)phenyl)boronic acid, 95.0%, 250mg

Balance d'analyse et de précision série Entris® II Modèles avec réglage externe, non certifiée, 0,01 g, 3200 g, BCE3202-1S

N-(2-CYANOETHYL)-N-METHYLBENZAMIDE, 90.0%, 250mg

tert-Butyl 2-bromo-6,7-dihydrothiazolo[4,5-c]pyridine-5(4H)-carboxylate, 95.0%, 250mg

2-Bromo-3,4-dichloro-6-fluorotoluene, 1g

4-Hydroxy-3-(trifluoromethyl)acetophenone, 95.0%, 5g

2-(4-(Azetidin-3-yl)piperazin-1-yl)pyrimidine hydrochloride, 97.0%, 100mg